With many colleagues, I shared an interest how to support the intestinal microbiota. However, we identified the lack of products with sufficient manufacturing quality.
Based on community-driven discussions about this unmet need, I and Philipp Novak founded Neobiomics in 2016. The mission was to make a low-tech intervention available in a high-quality format.
Since 2016, Neobiomics have worked together with Chr. Hansen, a Danish company being a world leading manufacturer of live bacterial cultures. ProPrems®, the result of that collaboration, will be provided in Europe during 2019.
With roots in neonatal care and academia, Neobiomics will dedicate a fair part of the surplus to research and product development, once business is self-propelling.
We will do good business for a good cause.
Stefan Johansson, MD PhD
CEO of Neobiomics